Logo

Insurer Aetna Sets Coverage Rates for Genomic Health's Oncotype DX

Nov 28, 2006
NEW YORK (GenomeWeb News) — Genomic Health today said that Aetna has set payment rates for its Oncotype DX test for early-stage breast cancer patients.
 
Genomic Health said Aetna, which  began covering the test in August, has set rates for all of its plans for breast cancer patients for the test, which quantifies the odds of breast cancer recurrence and predicts the chances of the effectiveness of chemotherapy treatment.

Breaking News
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.